Hubert Curcio

Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer

Jordi Remón, Benjamin Besse, Santiago Ponce Aix et al. · Journal of Clinical Oncology · 2024 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

ICARUS-LUNG01: A phase 2 study of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), with sequential tissue biopsies and biomarkers analysis to predict treatment outcome.

David Planchard, Nathalie Cozic, Marie Wislez et al. · Journal of Clinical Oncology · 2024 · 23 citations

Medicine, Oncology, Pharmacology +14

Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study

Maud Velev, Cécile Dalban, Christine Chevreau et al. · European Journal of Cancer · 2023 · 17 citations

Medicine, Nephrology, Oncology +15

LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer

Aurélie Swalduz, Camille Schiffler, Hubert Curcio et al. · Journal of Thoracic Oncology · 2024 · 12 citations · Full text

Medicine, Oncology, Pathology +17